Endocrine System/Treatment of Diabetes & Obesity Flashcards
Blood glucose-reducing hormones
Insulin
MoA:
Stimulation of glucose uptake by cells
Indication:
Type 1 and type 2 diabetes mellitus
Adverse Effects/Interactions:
Hypoglycaemia
Digoxin, beta-blockers
Oral Biguanide
Metformin
MoA:
Increases insulin sensitivity, inhibits hepatic gluconeogenesis
Indication:
Type 2 diabetes
Adverse Effects/Interactions:
Nausea and vomiting
Diuretics, digoxin
Sulphonylureas
Gliclazide
MoA:
Stimulates pancreatic insulin secretion
Indication:
Type 2 diabetes
Adverse Effects/Interactions:
Hypoglycaemia
Warfarin, NSAIDs
Thiazolidinediones
Pioglitazone
MoA:
Increases insulin sensitivity in muscle and adipose tissue
Indication:
Type 2 diabetes
Adverse Effects/Interactions:
Weight gain
Glucagon-like peptide-1 receptor (GLP-1) agonist
Exenatide
MoA:
Incretin analogue – improves glucose control
Indication:
Type 2 diabetes
Adverse Effects/Interactions:
Asthenia
Dipeptidyl peptidase-4 (DPP-4) Inhibitor
Sitagliptin
MoA:
Reduces inactivation of incretins
Indication:
Type 2 diabetes
Adverse Effects/Interactions:
Headache
SGLT-2 Inhibitor
Empagliflozin, Dapagliflozin
MoA:
Blockade of renal Na-glucose transporter – increases urinary excretion of blood glucose
Indication:
Type 2 diabetes
Adverse Effects/Interactions:
Urinary infection
Lipase inhibitor
Orlistat
MoA:
Inhibition of GI uptake of dietary fat
Indication:
Obesity, especially in presence of Type-2 diabetes
Adverse Effects/Interactions:
Oily stools, faecal urgency
Thyroid hormones
Levothyroxine sodium (T4) Liothyronine sodium (T3)
MoA:
Synthetic hormones
Indication:
Hypothyroidism
Adverse Effects/Interactions:
Diarrhoea, vomiting
Oral anti-coagulants